Cite
HARVARD Citation
van Schaik, I. et al. (n.d.). 18. Secondary endpoints (PATH extension study): Long-term outcomes of subcutaneous immunoglobulin IgPro20 in CIDP maintenance treatment. Clinical neurophysiology. 131 (3), pp. e8-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
van Schaik, I. et al. (n.d.). 18. Secondary endpoints (PATH extension study): Long-term outcomes of subcutaneous immunoglobulin IgPro20 in CIDP maintenance treatment. Clinical neurophysiology. 131 (3), pp. e8-. [Online].